Granite Bay Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,413
Closed -$394K 211
2023
Q4
$394K Sell
4,413
-11,400
-72% -$959K ﹤0.01% 264
2023
Q3
$1.76M Buy
+15,813
New +$1.76M 0.02% 178

Other funds holding MRNA

Granite Bay Wealth Management's MRNA Position: Q1 2024 in Review

Granite Bay Wealth Management sold out of Moderna (MRNA) in Q1 2024, closing a stake of 4,413 shares — an estimated $394K sold.

Granite Bay Wealth Management first reported a position in MRNA in Q3 2023 and held it in 2 quarters. The position peaked at $1.76M in Q3 2023. 902 funds tracked by Wall St. Rank hold MRNA as of Q1 2024.

  • Granite Bay Wealth Management reported no remaining Moderna position as of Q1 2024 after selling out during the quarter.
  • Granite Bay Wealth Management sold 4,413 Moderna shares in Q1 2024, an estimated $394K.
  • Granite Bay Wealth Management first reported a position in Moderna in Q3 2023 and held it in 2 quarters.
  • Granite Bay Wealth Management's Moderna position peaked at $1.76M in Q3 2023.
  • 902 funds tracked by Wall St. Rank held Moderna as of Q1 2024.

Based on Granite Bay Wealth Management's 13F filing for Q1 2024, filed 30 Apr 2024.